Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 22, 2023

Immediate vs Staged Complete Revascularisation in Patients With Acute Coronary Syndrome and Multivessel Disease

The Lancet


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial
Lancet 2023 Mar 03;[EPub Ahead of Print], R Diletti, WK den Dekker, J Bennett, CE Schotborgh, R van der Schaaf, M Sabaté, R Moreno, K Ameloot, R van Bommel, D Forlani, B van Reet, G Esposito, MT Dirksen, WPT Ruifrok, BRC Everaert, C Van Mieghem, JJ Elscot, P Cummins, M Lenzen, S Brugaletta, E Boersma, NM Van Mieghem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading